Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
Read MoreIf men are using transdermal estradiol for control of ADT-related side effects, does dose matter?
Short-Term Effects of Transdermal Estradiol in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer: A Randomized Placebo-Controlled Trial.
Read More
Can a lifestyle intervention impact self-efficacy of men on ADT?
Key sentence from the study abstract: “Findings from the IDEA-P trial suggest that the intensive phase of the EX+D intervention, implementing a GMCB approach designed to promote adoption and adherence to lifestyle behavior change, resulted in superior changes in select SCT outcomes relative to SC approach.”
Read MoreAre exercise programs more beneficial if they are initiated at the onset of ADT?
Key sentence from this abstract: “Exercise either at the onset or after 6 months ADT preserves/enhances muscle strength and physical function. However, to avoid any initial treatment-related adverse effects on strength and function, exercise should be prescribed and commenced at the onset of ADT”
Read MoreOur Twitter account
https://twitter.com/LifeOnADT
Read MoreDoes intermittent ADT (IADT) have lower risk of serious side effects than continuous ADT (CADT)?
Key sentence from the paper: “…the IADT group showed consistent reduced risk of these serious toxicities compared to the CADT group in both subgroups with or without comorbidities...”
Read MoreDoes ADT reduce the need to wake up at night to pee?
Key sentence from the paper: “In contrast to patients with moderate to severe [lower urinary tract symptoms], nocturia showed a significant increase during ADT therapy in patients with mild symptoms.”
Read MoreWhat’s the latest on ADT research?
Key sentence from the paper: “All clinical trials of newer agents… in [metastatic castrate-resistant prostate cancer] include patients who maintain castrate levels of testosterone, and so clinical practice should adhere to this principle of continuing ADT when initiating abiraterone, enzalutamide or chemotherapy.”
Read MoreDoes ADT increase the risk of pneumonia?
Key sentence from the paper: "The use of ADT is associated with an increased risk of hospitalisation for community-acquired pneumonia in men with prostate cancer.”
Read MoreDoes surgery or radiotherapy carry an increased risk of cardiovascular disease and bone fractures (independent of ADT)?
Key sentence from the paper: “… treatments with radiotherapy…and ADT…were each independently associated with increased risk of coronary heart disease, sudden cardiac death, fracture, and fracture requiring hospitalization.”
Read More